awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34098873-585D8C99-BF4D-4797-94F1-6A66D94F0489
Q34098873-585D8C99-BF4D-4797-94F1-6A66D94F0489
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34098873-585D8C99-BF4D-4797-94F1-6A66D94F0489
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.
P2860
Q34098873-585D8C99-BF4D-4797-94F1-6A66D94F0489
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34098873-585D8C99-BF4D-4797-94F1-6A66D94F0489
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77e9e35e68e5f051c9345074375a2fc1561e47e7
P2860
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.